epilepsy adherence in children and technology (eact)

Conditions: Epilepsy

Summary: fifty-eight percent of children with new-onset epilepsy do not take their antiepileptic drugs (aeds) as prescribed, which is associated with continued seizures, mortality, poor quality of life, and high healthcare costs. evidence-based adherence interventions are lacking and critically needed, especially for children with epilepsy, who represent an underserved population in pediatrics. the current proposal is a mhealth sequential, multiple assignment, randomized trial (smart) focused on providing education, automated digital reminders, and individualized adherence feedback, as well as teaching problem-solving skills, with the goal of improving adherence and quality of life and decreasing seizures and health care utilization.

non-adherence to antiepileptic drugs (aeds) is a common problem (i.e., 58% of patients have some level of non-adherence) for young children with newly diagnosed epilepsy, with potentially devastating consequences. aed non-adherence is associated with a 3-fold increased risk of seizures, poor quality of life, inaccurate clinical decision-making, and higher health care utilization and costs. one of the primary barriers to adherence is forgetting, which may be particularly amenable to mhealth (mobile technology in healthcare) interventions. despite the critical need to develop and implement interventions to improve adherence, there are few family-based interventions for young children with epilepsy and their families. one existing intervention is highly promising; however, this intervention requires six in-person sessions, which can be impossible for families who lack routine access to tertiary specialty care due to time, financial, or transportation constraints. thus, unmet medical and psychosocial needs of the underserved pediatric epilepsy population are perpetuated and compounded by limited access to this state of the art care. the overall goal is to test a mhealth adherence intervention that is easily accessible using a stepped up care model based on individual needs. this stepped up care model will conserve patient, family, and provider time, costs and resources. the aim of this multi-site r01 is to conduct a two-stage, sequential, multiple assignment, randomized trial (smart) to evaluate the effectiveness of mhealth intervention strategies for improving aed adherence in caregivers of young children with epilepsy. a two-month baseline period will be followed by two stages. in stage 1 (3-months long), non-adherent caregivers (\ 95% (response) by the end of stage 1 will be re-randomized to either continued individualized adherence feedback or individualized adherence feedback augmented with two mhealth problem-solving modules (translated from the pis existing rcts) with a therapist. thus, there are three intervention strategies embedded in this smart: #1 control, #2 treatment, and #3 problem-solving augmented treatment if nonresponsive at three months. the primary outcome is electronically-monitored adherence and secondary outcomes include seizure severity/frequency, quality of life, and healthcare utilization. if the aims of the project are achieved, this study would have a large impact on pediatric epilepsy, with the potential to change clinical practice for treating non-adherence. the smart design would allow the investigators to identify patients who are most likely to respond to interventions and step up care with more time- and resource-intensive interventions (i.e., problem-solving with a therapist via the web), when necessary.

Eligibility criteria:
inclusion criteria: 1. children ages 2-12 years 2. epilepsy diagnosis \< 2 years 3. ability to read/speak english exclusion criteria: 1. major comorbid neurodevelopmental or medical disorders (e.g., autism, diabetes) 2. plan to wean aeds for 18 months

Keywords: adherence mhealth ehealth children caregivers compliance